BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
32 results:

  • 1. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in pancreatic cancer.
    Jiang W; Du Y; Zhang W; Zhou W
    Can J Gastroenterol Hepatol; 2022; 2022():4661929. PubMed ID: 36406148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bifacial PNAs Destabilize malat1 by 3' A-Tail Displacement from the U-Rich Internal Loop.
    Miao S; Bhunia D; Devari S; Liang Y; Munyaradzi O; Rundell S; Bong D
    ACS Chem Biol; 2021 Aug; 16(8):1600-1609. PubMed ID: 34382766
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long noncoding RNAs: role and contribution in pancreatic cancer.
    Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
    Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Regulation of a long noncoding RNA malat1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues.
    Lee JE; Cho SG; Ko SG; Ahrmad SA; Puga A; Kim K
    Biochem Biophys Res Commun; 2020 Nov; 532(4):563-569. PubMed ID: 32900487
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exercise-mediated downregulation of malat1 expression and implications in primary and secondary cancer prevention.
    Paronetto MP; Dimauro I; Grazioli E; Palombo R; Guidotti F; Fantini C; Sgrò P; De Francesco D; Di Luigi L; Capranica L; Caporossi D
    Free Radic Biol Med; 2020 Nov; 160():28-39. PubMed ID: 32768573
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions.
    Kumar SR; Kimchi ET; Manjunath Y; Gajagowni S; Stuckel AJ; Kaifi JT
    Sci Rep; 2020 Feb; 10(1):2800. PubMed ID: 32071328
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. In Situ Hybridization Analysis of Long Non-coding RNAs malat1 and HOTAIR in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Chu YH; Hardin H; Eickhoff J; Lloyd RV
    Endocr Pathol; 2019 Mar; 30(1):56-63. PubMed ID: 30600442
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing.
    Zhang L; Yu S; Wang C; Jia C; Lu Z; Chen J
    Int J Oncol; 2018 Dec; 53(6):2659-2670. PubMed ID: 30221677
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
    Cheng Y; Imanirad P; Jutooru I; Hedrick E; Jin UH; Rodrigues Hoffman A; Leal de Araujo J; Morpurgo B; Golovko A; Safe S
    PLoS One; 2018; 13(2):e0192264. PubMed ID: 29389953
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Study on mechanism about long noncoding RNA malat1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
    Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
    J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quantitative proteomics reveals that long non-coding RNA malat1 interacts with DBC1 to regulate p53 acetylation.
    Chen R; Liu Y; Zhuang H; Yang B; Hei K; Xiao M; Hou C; Gao H; Zhang X; Jia C; Li L; Li Y; Zhang N
    Nucleic Acids Res; 2017 Sep; 45(17):9947-9959. PubMed ID: 28973437
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.
    Clawson GA; Matters GL; Xin P; McGovern C; Wafula E; dePamphilis C; Meckley M; Wong J; Stewart L; D'Jamoos C; Altman N; Imamura Kawasawa Y; Du Z; Honaas L; Abraham T
    PLoS One; 2017; 12(9):e0184451. PubMed ID: 28957348
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The lncRNA malat1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
    Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
    Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long Non-Coding RNA malat1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
    Chen L; Yao H; Wang K; Liu X
    J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MiR-216a decreases malat1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.
    Zhang Y; Tang X; Shi M; Wen C; Shen B
    Biochem Biophys Res Commun; 2017 Feb; 483(2):816-822. PubMed ID: 28034748
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long Noncoding RNA malat1 Promotes Aggressive pancreatic cancer Proliferation and Metastasis via the Stimulation of Autophagy.
    Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B
    Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
    Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
    Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
    Taucher V; Mangge H; Haybaeck J
    Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.